These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 15824416)

  • 21. Focus on breast and ovarian cancer.
    Borini A; Rebellato E
    Placenta; 2008 Oct; 29 Suppl B():184-90. PubMed ID: 18790331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation.
    Oktay K; Sonmezer M
    Hum Reprod; 2004 Mar; 19(3):477-80. PubMed ID: 14998939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assisted reproduction and breast cancer.
    Sonmezer M; Atabekoglu C
    Minerva Ginecol; 2007 Aug; 59(4):403-14. PubMed ID: 17923831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients.
    Turan V; Bedoschi G; Moy F; Oktay K
    Fertil Steril; 2013 Dec; 100(6):1681-5.e1. PubMed ID: 24055050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy.
    Das M; Shehata F; Son WY; Tulandi T; Holzer H
    Hum Reprod; 2012 Aug; 27(8):2509-14. PubMed ID: 22617122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer.
    Oktay K; Turan V; Bedoschi G; Pacheco FS; Moy F
    J Clin Oncol; 2015 Aug; 33(22):2424-9. PubMed ID: 26101247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
    Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
    J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.
    Fatum M; McVeigh E; Child T
    Hum Fertil (Camb); 2013 Dec; 16(4):235-40. PubMed ID: 23863119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
    Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
    Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.
    Turan V; Bedoschi G; Emirdar V; Moy F; Oktay K
    Reprod Sci; 2018 Jan; 25(1):26-32. PubMed ID: 28874104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination.
    Bedaiwy MA; Shokry M; Mousa N; Claessens A; Esfandiari N; Gotleib L; Casper R
    Fertil Steril; 2009 Jun; 91(6):2501-7. PubMed ID: 18501899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
    Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
    J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of spindle characteristics and embryo quality in mice stimulated with letrozole using Polscope imaging.
    Ganesh A; Chattopadhyay R; Narendra Babu K; Chakravarty B; Chaudhury K
    Fertil Steril; 2010 Mar; 93(5):1477-81. PubMed ID: 19646690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of letrozole or tamoxifen coadministered with a standard stimulation protocol on fertility preservation among breast cancer patients.
    Shulman Y; Almog B; Kalma Y; Fouks Y; Azem F; Cohen Y
    J Assist Reprod Genet; 2021 Mar; 38(3):743-750. PubMed ID: 33409757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation.
    Oktay K
    J Clin Oncol; 2005 Jun; 23(16):3858-9. PubMed ID: 15911867
    [No Abstract]   [Full Text] [Related]  

  • 37. Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?
    Kaufmann M; Rody A
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):146-54. PubMed ID: 16621229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to ovarian stimulation in patients facing gonadotoxic therapy.
    Johnson LN; Dillon KE; Sammel MD; Efymow BL; Mainigi MA; Dokras A; Gracia CR
    Reprod Biomed Online; 2013 Apr; 26(4):337-44. PubMed ID: 23415997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles.
    Sönmezer M; Türkçüoğlu I; Coşkun U; Oktay K
    Fertil Steril; 2011 May; 95(6):2125.e9-11. PubMed ID: 21292255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.